BOR CHUANG: Open Payments
NPI 1003997255 · COPIAGUE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,246 in 69 payments from 10 companies in 2025. Trend: 2023 $2,138 · 2024 $3,084 · 2025 $3,246
Food & beverage: $3,246
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 18 | $734 |
| E.R. Squibb & Sons, L.L.C. | 10 | $587 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $465 |
| Otsuka America Pharmaceutical, Inc. | 7 | $461 |
| Teva Pharmaceuticals USA, Inc. | 7 | $419 |
| Janssen Pharmaceuticals, Inc | 7 | $194 |
| Lundbeck LLC | 6 | $144 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Luye Pharma (USA) Ltd. | 2 | $48 |
Products named: COBENFY, ARISTADA, CAPLYTA, ABILIFY MAINTENA, UZEDY, LYBALVI, REXULTI, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
